MedTrace Logo

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

NCT02988739 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-03-06

No results posted yet for this study

Summary

It is the aim of the present study to compare the immunogenicity induced by a laser-assisted epidermally administered seasonal influenza vaccine to an intradermally administered seasonal influenza vaccine.

Conditions

  • Influenza in Human

Interventions

BIOLOGICAL

seasonal influenza vaccine

influenza vaccine containing 15 µg haemagglutinin of three seasonal influenza virus strains recommended by WHO

DEVICE

fractional Er:Yag laser

Fraction laser device to apply micorpores of defined depth and density into skin.

Sponsors & Collaborators

  • Medical University of Vienna

    collaborator OTHER

  • Pantec Biosolutions AG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-22
Primary Completion
2017-07-31
Completion
2017-09-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02988739 on ClinicalTrials.gov